Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Watch Coca-Cola HBC AG (CDI) (CCH) by Stephen Wright in The Motley Fool
- Watch Nexus Infrastructure (NEXS) by Steve Moore in ShareProphets
- Avoid WPP (WPP) by Steve Moore in ShareProphets
- Buy Amaroq Minerals Ltd. Npv (DI) (AMRQ) by Tom Winnifrith in ShareProphets
- Buy Amaroq Minerals Ltd. Npv (DI) (AMRQ) by Steve Moore in ShareProphets
- Hold Sylvania Platinum Ltd (DI) (SLP) by Tom Winnifrith in ShareProphets
- Hold Sylvania Platinum Ltd (DI) (SLP) by Steve Moore in ShareProphets
- Sell Ocado Group (OCDO) by Steve Moore in ShareProphets
- Neutral Aston Martin Lagonda Global Holdings (AML) by Citi
- Buy Glencore (GLEN) by Citi
- Buy London Stock Exchange Group (LSEG) by UBS
- Market Perform WPP (WPP) by Bernstein
- Buy Jet2 (JET2) by UBS
- Sell WPP (WPP) by UBS
- Equal Weight WPP (WPP) by Barclays
- Sell HSBC Holdings (HSBA) by Shore Capital
- Buy Luceco (LUCE) by Deutsche Bank
- Sell Haleon (HLN) by Deutsche Bank
- Buy Man Group (EMG) by Deutsche Bank
- Underweight Ocado Group (OCDO) by Barclays
Synairgen (SNG) Share Price
Health Care Sector
NOTE: This is based on 29 open tips for Synairgen (SNG)
| Latest Bid : 0.60p | Latest Ask : 1.20p |
| High Today : 1.28p | Low Today : 0.70p |
| This Years High : 5.46p | This Years Low : 0.70p |
| Volume : 1,625,837 | MKT Cap : £1.92M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Synairgen (SNG) Overview
In the 1970s, Synairgen founder, British immunophysician Professor Sir Stephen Holgate, began investigating how respiratory viruses can cause serious illness, with the aim of translating these insights into effective clinical treatments. Joined by fellow University of Southampton professors Donna Davies and Ratko Djukanovic in the 1990s, together the three formed Synairgen in 2003 with the sole aim of bringing these advances to patients.Synairgen (SNG) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Nadia Yaqub | Premium Only | 2021-01-27 18:00:00 27/01/2021 | -96.50% |
| Sell | Richard Evans | Premium Only | 2021-01-21 10:25:00 21/01/2021 | -10.92% |
| Sell | Richard Evans | Premium Only | 2021-01-20 09:20:00 20/01/2021 | -3.91% |
| Buy | Nadia Yaqub | Premium Only | 2021-01-19 13:30:00 19/01/2021 | -96.26% |
| Buy | Nadia Yaqub | Premium Only | 2020-12-31 11:35:00 31/12/2020 | -96.14% |
Synairgen (SNG) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.60p | Latest Ask : 1.20p |
| High Today : 1.28p | Low Today : 0.70p |
| This Years High : 5.46p | This Years Low : 0.70p |
| Volume : 1,625,837 | MKT Cap : £1.92M |
Synairgen Overview
In the 1970s, Synairgen founder, British immunophysician Professor Sir Stephen Holgate, began investigating how respiratory viruses can cause serious illness, with the aim of translating these insights into effective clinical treatments. Joined by fellow University of Southampton professors Donna Davies and Ratko Djukanovic in the 1990s, together the three formed Synairgen in 2003 with the sole aim of bringing these advances to patients.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Synairgen Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Nadia Yaqub | Premium Only | 2021-01-27 18:00:00 27/01/2021 | -96.50% |
| Sell | Richard Evans | Premium Only | 2021-01-21 10:25:00 21/01/2021 | -10.92% |
| Sell | Richard Evans | Premium Only | 2021-01-20 09:20:00 20/01/2021 | -3.91% |
| Buy | Nadia Yaqub | Premium Only | 2021-01-19 13:30:00 19/01/2021 | -96.26% |
| Buy | Nadia Yaqub | Premium Only | 2020-12-31 11:35:00 31/12/2020 | -96.14% |